Inventor · disambiguated record
Hendricus Marie Janssen
Also filed as: JANSSEN HENDRICUS MARIE
10 granted patents·1 pending application·112 citations·filing 2003–2023
90Inventor score
Top patents by PatentIndex Score
11 records- 0194US9421274B2Bio-orthogonal drug activationROBILLARD MARC STEFAN·Filed 2012·Granted Aug 23, 2016·28 cites·4 claims
- 0294US7622131B2Siloxane polymers with quadruple hydrogen bonding unitsSUPRAPOLIX BV·Filed 2005·Granted Nov 24, 2009·30 cites·13 claims
- 0392US10376594B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2015·Granted Aug 13, 2019·11 cites·25 claims
- 0489US10004810B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2016·Granted Jun 26, 2018·6 cites·4 claims
- 0589US8247524B2Preparation of supramolecular polymers containing quadruple hydrogen bonding units in the polymer backboneJANSSEN HENDRICUS MARIE·Filed 2010·Granted Aug 21, 2012·11 cites·17 claims
- 0686US9931408B2Bio-orthogonal drug activationROBILLARD MARC STEFAN·Filed 2012·Granted Apr 3, 2018·7 cites·27 claims
- 0785US10967069B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2019·Granted Apr 6, 2021·1 cites·34 claims
- 0885US2024091371A1Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2023·Application pending·0 cites
- 0981US7838621B2Preparation of supramolecular polymer containing quadruple hydrogen bonding units in the polymer backboneSUPRAPOLIX BV·Filed 2003·Granted Nov 23, 2010·17 cites·24 claims
- 1076US11857636B2Bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2021·Granted Jan 2, 2024·0 cites·17 claims
- 1173US11617799B2Cleavable tetrazine used in bio-orthogonal drug activationTAGWORKS PHARMACEUTICALS B V·Filed 2017·Granted Apr 4, 2023·1 cites·41 claims
Join the waitlist — get patent alerts
Get an alert when Hendricus Marie Janssen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →